Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.
Martin VuKoen DegelingElla R ThompsonPiers A BlomberyDavid WestermanMaarten J IJzermanPublished in: European journal of haematology (2022)
Although there is initial confirmation of the promising health economic results, the present research for molecular biomarker tests in hematological malignancies is sparse with many applications of technological advances yet to be evaluated.